RAPT Competitors & Alternatives
Compare RAPT Therapeutics Inc with similar stocks in the same industry
Biotechnology
RAPT
Main Stock$58.02
Tradestie Score
50
Market Cap
$450.49M
Revenue Growth
-1.0%
Analyst Upside
0.0%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.37
|
$1.78B | - | 66 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.77
|
$1.78B | - | 57 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$135.47
|
$1.77B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$22.82
|
$1.74B | - | 45 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.97
|
$1.68B | - | 64 | Compare |
|
MNKD
Mannkind Corporation
|
$3.20
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.99
|
$1.63B | - | 58 | Compare |
|
BHVN
Biohaven Ltd.
|
$14.69
|
$1.57B | - | 37 | Compare |
|
VCEL
Vericel Corporation
|
$42.97
|
$1.56B | 87.1 | 49 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$78.53
|
$1.55B | - | 56 | Compare |
More RAPT Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry